EODData

NASDAQ, ALMS:

22 Aug 25 16:59
LAST:

4.840

CHANGE:
 0.24
OPEN:
4.610
HIGH:
4.870
ASK:
0.000
VOLUME:
692.4K
CHG(%):
5.22
PREV:
4.600
LOW:
4.610
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Aug 254.6104.8684.6104.840693.1K
21 Aug 254.4104.6104.3304.600444.4K
20 Aug 254.5704.7004.3604.410597.4K
19 Aug 254.9004.9004.4504.730603.5K
18 Aug 254.7405.1314.7104.8501.13M
15 Aug 254.4504.7704.4424.750865.3K
14 Aug 254.1604.4504.0914.390546.8K
13 Aug 254.4504.5704.2104.420731.5K
12 Aug 254.3504.6554.2804.4601.13M
11 Aug 254.2504.4404.2504.340824.6K

COMPANY PROFILE

Name:
About:Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company's clinical asset comprises ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. It also develops interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. The company was incorporated in 2021 and is headquartered in South San Francisco, California.
Sector:Healthcare
Industry:Biotechnology
Address:280 East Grand Avenue, South San Francisco, CA, United States, 94080
Website:https://www.alumis.com
ISIN:US0223071020
FIGI:BBG01J7X4PN2

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:0.14
PtB:1.01
PtS:24.54
Shares:96M
Market Cap:464.66M

TECHNICALS

MA5:4.69
MA10:4.58
MA20:4.37
MA50:3.73
MA100:4.34
MA200:5.75
STO9:60.73
STO14:68.74
RSI14:69.63
WPR14:-1.54
MTM14:0.64
ROC14:0.15
ATR:0.31
Week High:5.13
Week Low:4.33
Month High:5.13
Month Low:3.25
Year High:13.11
Year Low:2.76
Volatility:53.22